Stay updated on ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Sign up to get notified when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.

Latest updates to the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4. This indicates a small update to the page's metadata, without changing substantive content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer page revision. This update does not modify study details or user-facing content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page shows Revision: v3.6.3 in place of Revision: v3.6.2, indicating a small software update applied to the page rather than a change to the study data or details.SummaryDifference0.0%

- Check57 days agoChange DetectedA new revision tag Revision: v3.6.2 was added and the previous tag Revision: v3.6.0 was removed. This reflects a newer site release and does not alter study content or user-facing information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe study page now indicates recruitment is closed for participants, and several help/navigation items were added along with a revision/version note updating from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check78 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4, indicating a new version of the page content. This change reflects an update to the page’s version label rather than any visible content modification.SummaryDifference0.0%

Stay in the know with updates to ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC
Enter your email address, and we'll notify you when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.